Welcome to our dedicated page for Agronomics news (Ticker: AGNMF), a resource for investors and traders seeking the latest updates and insights on Agronomics stock.
Agronomics Limited (AGNMF) is a London-listed investment company focused on clean food and cellular agriculture, and its news flow reflects activity across a portfolio of more than 20 private companies in this emerging field. Company announcements cover new investments, follow-on funding, portfolio milestones and periodic updates on net asset value, giving readers insight into how Agronomics is deploying capital and how its holdings are progressing.
Recent news has highlighted additional investments in precision fermentation businesses, such as funding for All G Co Holdings Pty Limited, which develops human and bovine milk proteins like lactoferrin without the use of animals. Agronomics has also reported further equity investment in BlueNalu, Inc., a cell-cultivated seafood company working on products such as cultivated bluefin tuna toro for premium foodservice markets.
Updates on other portfolio companies include Liberation Bioindustries, which is building a commercial-scale precision fermentation facility to produce bio-based protein and other ingredients, Geltor, Inc., which has received an FDA “no questions” letter confirming GRAS status for its vegan collagen polypeptide PrimaColl, Clean Food Group Limited, which manufactures sustainable oils and fats through fermentation, and Onego Bio, whose precision-fermented egg protein Bioalbumen has also received an FDA GRAS “no questions” letter.
News items may also cover less favourable developments, such as the dissolution of Meatable B.V., and periodic net asset value calculations that summarise the impact of portfolio movements and foreign exchange changes on Agronomics’ balance sheet. For investors and observers interested in cellular agriculture and alternative proteins, the Agronomics news stream provides regular, company-sourced updates on financing rounds, regulatory progress and commercial partnerships across this specialised investment portfolio.
Onego Bio, a portfolio company of Agronomics (AGNMF), has achieved a significant regulatory milestone as the FDA issued a "no questions" letter regarding the GRAS status of its Bioalbumen® product. This egg protein alternative, produced through precision fermentation, can now be used as a dietary protein source and functional ingredient in various food applications.
The company plans to construct its flagship production facility in Jefferson County, Wisconsin, to scale manufacturing. Agronomics has invested £7.1 million in Onego Bio, with the position currently valued at £11.2 million, representing approximately 7.5% of Agronomics' Net Asset Value as of June 30, 2025.
Clean Food Group (CFG), a portfolio company of Agronomics (AGNMF), has achieved a significant milestone by receiving regulatory approval for its CLEAN Oil™ 25 product as a cosmetic ingredient in the UK, Europe, and United States. The precision-fermented oil offers a sustainable alternative to palm oil, which is currently used in 70% of cosmetic products.
Developed in collaboration with THG LABS and Croda International plc, this breakthrough targets the global personal care and cosmetics sector, projected to reach $776.35 billion by 2030. Agronomics' investment of £1.6 million in CFG is currently valued at £6.9 million, representing approximately 4.8% of Agronomics' last stated Net Asset Value as of June 2025.
Agronomics Limited (AGNMF) reported its unaudited Net Asset Value (NAV) as of June 30, 2025, at 14.40 pence per share, representing a 2.8% decrease from March 2025. The company's total Net Assets stood at £145.3 million, including £141.8 million in investments and £3.6 million in cash.
The quarter saw a £4.1 million decline in NAV, primarily due to unrealized FX losses of £4.2 million from currency fluctuations. Despite this, portfolio companies achieved significant milestones, including BlueNalu's expanded partnership with Nomad Foods, Liberation Bioindustries's strategic partnership with NEOM, and Meatable's collaboration with TruMeat for cultivated meat commercialization.
Agronomics Limited (AGNMF) reported its unaudited Net Asset Value (NAV) as of March 31, 2025, at 14.81 pence per share, representing a 0.80% decrease from December 2024. The company's Net Assets stand at £149 million, including £146 million in investments and £4 million in cash. The current share price of 7.15 pence represents a 52% discount to NAV.
Key portfolio developments include: Liberation Labs securing a $50.5M convertible note raise, Formo Bio obtaining a €35M EIB loan, and Solar Foods receiving €10M in government funding. Notable milestone: Good Dog Food (Meatly) became the first company to sell cultivated meat for pet food in Europe. The quarter saw a £1.2M NAV decline, mainly due to FX losses of £2.5M, partially offset by a £1.3M value increase in Solar Foods holding.
Agronomics (LSE:ANIC) announces a strategic collaboration between its portfolio company Meatable and TruMeat to advance cultivated meat commercialization. Meatable, a cultivated meat technology leader, will partner with TruMeat, a contract manufacturer, to build a state-of-the-art facility in Singapore using Meatable's technology.
The collaboration aims to optimize processes and media development to produce cultivated meat at competitive price points and commercial scale. Agronomics has invested €9.2 million in Meatable, currently valued at £11.4 million, representing approximately 7.5% of Agronomics' last stated Net Asset Value as of December 31, 2024.
The new facility will be Singapore's first to deliver cultivated meat at cost levels and volumes needed for commercial partners to formulate, test, and launch products in the market.
Agronomics announces the expansion of its portfolio company BlueNalu's partnership with Nomad Foods to commercialize cell-cultivated seafood in the UK and Europe. The partnership, first established in 2021, will focus on market entry through premium foodservice channels.
BlueNalu has joined the UK Food Standards Agency's regulatory program as the only company focused on cell-cultivated seafood. Recent research shows strong consumer interest, with 92% of UK sushi consumers eager to try BlueNalu's first commercial product, cell-cultivated bluefin tuna toro. Notably, 74% of consumers expressed willingness to pay the same or higher prices compared to conventional bluefin tuna.
Agronomics has invested US$8.0 million in BlueNalu, currently valued at £13.0 million, representing approximately 8.6% of Agronomics' Net Asset Value as of December 2024.
Agronomics (LSE:ANIC), a leading clean food company, has announced that an advisory consultant to Shellbay Investments has exercised nil paid options over 2,289,549 shares. The shares will be transferred immediately from Shellbay, which is indirectly owned by Jim Mellon, the Executive Chair of Agronomics.
Following this transaction, Shellbay now holds 24,097 Ordinary Shares, all of which remain subject to the 2024 Options. The company's total issued share capital remains unchanged at 1,009,417,295 ordinary shares with a nominal value of £0.000001.
Post-transaction, Jim Mellon maintains interest in 158,117,002 Ordinary Shares, with 152,710,944 held by Galloway , 24,097 by Shellbay, and 5,381,961 held directly. Richard Reed holds interest in 6,354,412 Ordinary Shares through Reepa